CopyMark Law Group
4.9/5
Drawing for CENCORA

USPTO serial 97765119

CENCORA

Reviewed by CopyMark Law Group

Status 732Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
KAJUBI, ELIZABETH N
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 732: Status 732 means the third six-month extension to file a Statement of Use was granted. You are past the midpoint of available extension time — plan SOU filing carefully.

Need help with CENCORA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $249*

Plus Government fees of $150

Trademark Monitoring(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Anita B. Polott

Anita B. Polott MORGAN, LEWIS & BOCKIUS LLP1111 PENNSYLVANIA AVENUE, NWATTENTION: TMSUWASHINGTON, DC 20004-2541

Goods and services

ClassDescriptionStatusFirst use
035Wholesale distributorship services in the field of pharmaceuticals, medical and healthcare products; wholesale ordering services featuring pharmaceutical, medical and healthcare products; wholesale distributorship services in the field of specialty pharmaceutical products, namely, disease specific pharmaceuticals; wholesale ordering services featuring specialty pharmaceutical products, namely, disease specific pharmaceuticals; wholesale distributorship services featuring specialty healthcare products in the nature of pharmaceuticals and chemotherapeutics supplied in accordance with specially developed protocols to health-care providers and their patients; wholesale ordering services featuring specialty healthcare products in the nature of pharmaceuticals and chemotherapeutics supplied in accordance with specially developed protocols to health-care providers and their patients; Wholesale distributorship services featuring pharmaceuticals, medical and surgical supplies, healthcare and beauty aid products; wholesale pharmaceutical and medical supply distributorship services; mail order retail ordering services featuring pharmaceutical and biotechnological products; wholesale distributorship services in the field of animal health and veterinary products; wholesale distributorship services in the field of veterinary supplies featuring animal care and grooming products, animal nutritional supplements and medication; wholesale ordering services featuring veterinary supplies featuring animal care and grooming products, animal nutritional supplements and medication; ordering services for purchasing pharmaceuticals, namely, computerized online ordering featuring pharmaceuticals; business consulting in the field of development and commercialization of biotechnological products; providing an online computer database featuring information about consumer product sales at retail locations, about wholesale product sales to outlets, and about inventory management of health-care products for use by commercial entities; business consulting in the field of veterinary practice management; business consulting in the field of livestock management; business consulting services in the field of pharmaceuticals and other healthcare technologies; business consulting services in the field of pharmaceuticals and other healthcare technologies, including the application of analytical and statistical methodology to the study of healthcare products and their impact on the overall healthcare market; advertising and marketing services in the field of healthcare products and services; cost containment services in the field of healthcare providers and pharmacies relating to containing drug acquisition costs and recovering allowable reimbursements; healthcare business administration services; business management consulting services in the field of pharmaceutical and healthcare products and services; business management consulting services in the field of pharmaceutical and healthcare product manufacturing, distribution, and logistics, namely, analyzing data about product inventory and sales, managing formularies, and marketing such products; healthcare business administration services in the healthcare field for pharmaceutical, biotechnology and medical device suppliers; business consulting services in the field of cost and payment management of health care cost containment, namely, providing expedited review, processing and follow-up of prior authorization requests initiated by physicians' offices and pharmacies, providing group purchasing of pharmaceuticals and chemotherapeutics for community-based providers including oncologists and oncology practices; business consulting services in the field of cost and payment management of health care cost containment; business consulting services in the field of reimbursement for medical services rendered; conducting market research surveys in the field of healthcare costs and delivery cooperative advertising and marketing in the field of biotechnological products; providing information from an online non-downloadable database featuring information about consumer product sales at retail locations, about wholesale product sales to outlets, and about inventories of health-care products for use by commercial entities; retail pharmacy services featuring specialty pharmaceuticals and chemotherapeutics; professional staffing services, namely, temporary staffing for pharmacies; professional temporary staffing for pharmacies, namely, providing, recruiting, retaining pharmacy personnel, and interim managing of pharmacy operational and clinical functions; business management of customs brokers; tracking and monitoring import agency compliance for business purposes; customs clearance services; computerized tracking and tracing of documents, packages and freight in transit to ensure on-time delivery for business purposes; preparing business reports to insurance agencies regarding drug therapy efficacy; organization and conducting of business meetings in the field of development, commercialization, and distribution of products and services in the field of healthcare; providing business information via a global computer network and the Internet to commercial companies in the fields of wholesaling of goods at sales outlets, pharmaceutical preparation and healthcare preparation stock, and product performance for market research purposes; pharmaceutical business management services for others, namely, inventory management, product merchandising in the nature of inventory display and shelf arrangement and automated inventory monitoring services; business consulting and business research services in the areas of health economics and outcomes; retail drug store services; the bringing together, for the benefit of others of various pharmaceuticals, health products and non-brand medicines, health, beauty and pharmaceutical products, excluding the transport thereof, enabling customers to view and purchase those goods conveniently by means of retail stores, wholesale stores, vending machines, and mail order catalogues; business administration of consumer loyalty and incentive reward programs; cost price analysis, namely, providing services for pricing analysis; preparation of invoices; organizing promotional activities being events, exhibitions, fairs and shows on behalf of pharmacists for customer loyalty programs for commercial, promotional and advertising purposes; the bringing together, for the benefit of others, of various pharmaceuticals, therapeutic and generic medicines and generic medicines, excluding the transport thereof, enabling customers to conveniently view and purchase those goods by means of retail and wholesale outlets; preparing business reports, namely, providing pricing policy research reports; cost price analysis, namely, provision of price calculation analysis; price comparison services, namely, services that compare prices of goods or services from different sellers for easy reference and comparison by consumers to those sellers' goods or services; advertising, organization of exhibitions and trade fairs for the purpose of advertising and sales promotion; personnel placement, namely, personnel supply services; import-export agency services; window display arrangement services and product merchandising for others in the nature of inventory display and shelf arrangement; conducting business, market research and consumer surveys for statistical purposes on pharmaceuticals, commercial information on pharmaceuticals; business operation of pharmacies and of health and beauty stores of others; business operation of retail stores selling pharmaceuticals, cosmetics, food and beverages, spectacles, vitamins and healthcare products, toiletries and personal care products of others; providing healthcare consulting services in the healthcare field for pharmaceutical, biotechnology and medical device suppliers, namely, consulting services in the cost and payment management of health care for business purposes; group purchasing organization (GPO) services, namely, administering discount group programs, namely, negotiating contracts with providers of pharmaceuticals to obtain discounts on the purchase of their goods; buying club services, namely, organization and provision of buying groups; administering discount group purchasing programs for the pharmaceutical, healthcare and beauty industries by negotiation of contracts with providers of products and services to enable discounts to participant members; business administration of customer loyalty programs; procurement, namely, purchasing pharmaceutical, healthcare and beauty products for others; human resource analysis and consulting services; services for analyzing data about product inventory and sales, managing formularies, and marketing such products for business purposes; patient relationship management services, namely, providing patient adherence solutions through coordination across various levels of care with multidisciplinary care teams based on assessment and patient-centric planning and facilitation for services to meet a patient's needs through communication, education and available resources; patient relationship management services, namely, providing adherence solutions and patient-specific education in response to and as targeted by prescribed therapy; providing trade information, namely, preparing and distributing information brochures and notices to doctors, pharmacists, and the public on pharmaceutical products, disease prevention and control; dissemination of advertising materials of others in the nature of brochures and notices to doctors, pharmacists, and the public on pharmaceutical products, disease prevention and control; providing market research services to pharmaceutical and biotechnology companies through surveys of doctors, patients, pharmacists and others on pharmaceutical products and their usage; call center services for others, namely, operation and management of call centers for pharmaceutical and biotechnology companies for others; providing online business information relating to product performance and marketing research from a computer database or the Internet for use by commercial entities; regulatory submission management, namely, assisting others in preparing and filing pharmaceutical product submissions to government regulatory bodies on behalf of pharmaceutical and biotechnology companies; providing consulting services in the field of regulatory submission management to pharmaceutical and biotechnology companies on pharmaceutical product submissions to government regulatory bodies; commercial lobbying services, namely, promoting the interests of pharmaceutical and biotechnology companies through government lobbying services; brand positioning services, namely, provision of brand equalization programs; franchising, namely, consultation and assistance in business management, organization and promotion; administration of business affairs of franchises, namely, organization and promotion services related to franchise agreements; distribution of prospectuses; management of computer files; brand positioning services, namely, provision of brand alignment projects and programs to promote them evenly in the goods and services market; office administration services; secretarial services; compilation of statistics; rental of office machinery and equipment; systematization of information in computer databases; telephone answering services; accounting services; personnel recruitment; human resources services, namely, personnel selection for others; personnel placement, namely, temporary personnel assignment services; business data analysis, namely, discount analysis; business administration of group discount purchasing; preparing of financial reports for others; preparing business reports, namely, provision of management reports; business management consultancy and assistance services; computerized on-line ordering services in the field of office supplies and office equipment; retail store services featuring veterinary supplies and animal care and grooming products, animal nutritional supplements and medication; inventory management; livestock management services for managing livestock for others on an individual animal and herd basis for both dairy animals and meat producing animals, namely, providing customized business management services for individual animal information collection and business management; providing information on marketing in the field of animal management; business management and preparation of business reports for others, namely, recording and managing inventories of pharmaceuticals for business purposes, preparation of business reports in the field of feed and other consumed products, managing quality assurance by monitoring nutrition, weight and health of individual animals with milk or meat withholds for business purposes, providing individual animal identification tracking, trace-back and monitoring services through its supply chain for compliance with process, age, source and N.A.I.S. requirements for business purposes, creating business management reports concerning the foregoing on an individual animal and herd basis, namely, creating financial reports, and graphs, profit and loss statements, milk and/or meat products reports and graphs, medical and health reports and graphs, treatment histories and future protocol treatments, feed ration intake and adjustment reports, and individual animal expense reports all for business management purposes; Marketing services in the field of animal health products; marketing services, namely, promoting retail sale of products for animal use; Retail mail order services featuring veterinary pharmacy products; Retail pharmacy services, namely, a licensed pharmacy serving veterinarians and their clients by filling prescriptions from veterinarians with applicable product uses and directions; Distributorships in the field of specialty pharmaceutical products; distributorship services for livestock and commercial feedmills in the field of livestock medications, chemicals, nutrients, and growth stimulants; retail services by direct solicitation by sales agents featuring computer hardware, computer software, radio frequency animal identification tags, and radio frequency identification tag technology, all of the foregoing capable of utilizing a uniform set of database standards for tracking and tracing back movements of individual animals in the meat and dairy industries through a supply chain from producers to processor back to market; retail pharmacy services; providing sales and marketing information in the field of pharmacy drugs being distributed and communicated through CD-rom, diskette or the Internet; business administration of pharmacies; promotion services for professionals in the field of advancement of pharmaceutical and health industries for the purpose of facilitating networking and socializing opportunities for business purposes and for the purpose of promoting the services of others; business information services for the pharmaceutical and medical industries regarding product commercialization, product distribution, operations, logistics, reverse logistics, supply chain, production systems, distribution solutions, regulation compliance, supply and demand forecasting, clinical trial logistics, direct to patient logistics, temperature-controlled logistics; consulting services in the field of animal medical practice management for others relating to research, development, analysis and identification of processes to efficiently raise individual animals; distributorship services in the field of medical devices; third party logistics services, namely, freight logistics managementACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 2, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 2, 2026EX3GSOU EXTENSION 3 GRANTED—
Jul 1, 2026EXT3SOU EXTENSION 3 FILED—
Jul 1, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 31, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 30, 2025EX2GSOU EXTENSION 2 GRANTED—
Dec 30, 2025EXT2SOU EXTENSION 2 FILED—
Dec 30, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 3, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 3, 2025EX1GSOU EXTENSION 1 GRANTED—
Jul 3, 2025EXT1SOU EXTENSION 1 FILED—
Jul 3, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 7, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 26, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 26, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 20, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 31, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 29, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 29, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 29, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 3, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 3, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 3, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 28, 2024DMCCDATA MODIFICATION COMPLETED—
May 28, 2024ALIEASSIGNED TO LIE—
Apr 18, 2024AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Apr 18, 2024PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Apr 18, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 18, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 18, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 16, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Jan 16, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Oct 19, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 19, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 19, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 19, 2023DOCKASSIGNED TO EXAMINER—
Oct 18, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Feb 13, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 26, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance